|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria 显示文摘 | Pillar CM Zureno GE | 2009 | Antimicrob Agents Chemother2009，53，8： | 1 |
| 2 | Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria显示文摘 | HAAS W PILLAR CM ZURENKO GE | 2009 | Antimicrob Agents Chemother2009，53，8： | 1 |
| 3 | In vitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth mierodilution and Etest显示文摘 | Pillar CM Draghi DC Dowzieky MJ | 2008 | J Clin Microbiol2008，46，9： | 1 |
| 4 | Activities of carbapenem and cornparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program显示文摘 | Morrow BJ Pillar CM Deane J | 2013 | Diagn Microbiol Infect Dis2013，75，4： | 1 |
| 5 | In vitro activity of tigecycline against Gram positive and Gram-negative pathogens as evaluated by broth microdilution and Etest显示文摘 | Pillar CM Draghi DC Dowzicky MJ | 2008 | J Clin Microbiol2008，46，9： | 1 |
| 6 | In vitro activity of tigecycline against grampositive and gram - negative pathogens as evaluated by broth rnicrodilution and Etest 显示文摘 | Pillar CM Draghi DC Dowzicky MJ | 2008 | J Clin Microbiol2008，46，28： | 1 |
| 7 | Activities of carbap- enem and comparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program显示文摘 | Morrow BJ Pillar CM Deane J | 2013 | Diagn Microbiol Infect Dis2013，75，4： | 1 |
| 8 | In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-posi- tive and gram-negative isolates of European origin 显示文摘 | Pillar CM Aranza MK Shah D | 2008 | J AntimicrobChemother2008，61，3： | 1 |
| 9 | Activities of carbapenem and comparator agents against contemporary US Pseudomonas aerug- inosa isolates from the CAPITAL surveillance program 显示文摘 | Morrow BJ Pillar CM Deane J | 2013 | Diagn Microbiol Infect Dis2013，75，： | 1 |
| 10 | Enterococcus faecalis senses target cells and in response expresses cytolysin 显示文摘 | Cobum PS Pillar CM Jett BD | 2004 | Science2004，306，5705： | 1 |
| 11 | In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram negative bacteria, against recent clinical isolates from the United States显示文摘 | Pillar CM Torres MK Brown NP | 2008 | Antimicrob Agents Chemother2008，52，12： | 1 |
| 12 | Activities of earbapenem and comparator agents against contemporary US Pseudomonas aerug- inosa isolates from the CAPITAL surveillance program 显示文摘 | Morrow BJ Pillar CM Deane J | 2013 | Diag Microbiol Infect Dis2013，75，： | 1 |
| 13 | Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae显示文摘 | Haas W Pillar CM Hesje CK | | JAntimicrobChemother0，65，7： | 1 |
| 14 | Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria显示文摘 | Haas W Pillar CM Zurenko GE | 2009 | Antimicrob Agents Chemother2009，53，8： | 1 |
| 15 | Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria显示文摘 | HAAS W PILLAR CM ZURENKO GE | 2009 | Antimicrob Agents Chemoth- er2009，53，8： | 1 |
| 16 | Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates显示文摘 | Arhin FF Draghi DC Pillar CM | 2009 | Antimicrob Agents Chemother2009，53，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员